Related Experiment Videos
Treatment of alkalosis with ammonium chloride: a case report
Clinical Pharmacology and Therapeutics
|May 1, 1979
Abstract:
Coma due to ammonium chloride used in the treatment of severe metabolic alkalosis is reported in a patient with normal hepatic and renal function. All symptoms resolved following discontinuance. Ammonium chloride should be abandoned as a treatment for metabolic alkalosis.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
ANG1005 for breast cancer brain metastases: correlation between 18F-FLT-PET after first cycle and MRI in response assessment.
Breast cancer research and treatment·2016
Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.
Bone marrow transplantation·2016
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib.
United European gastroenterology journal·2015
Oral disease profiles in chronic graft versus host disease.
Journal of dental research·2015
Advancing Regulatory Adoption of New Approach Methodologies.
Clinical pharmacology and therapeutics·2026
Perspective on Pharmacokinetic Comparability for Biologics Development.
Clinical pharmacology and therapeutics·2026
Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer.
Clinical pharmacology and therapeutics·2026
Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer.
Clinical pharmacology and therapeutics·2026
N-Alkylpyridinium sulfonates as versatile scout compounds for multi-mode highly targeted metabolomics: Application to Gammarus fossarum.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026